US2017100441A1PendingUtilityA1

Composition for treatment of vitiligo

Assignee: MIKAELIAN ARTHURPriority: Nov 13, 2007Filed: Dec 22, 2016Published: Apr 13, 2017
Est. expiryNov 13, 2027(~1.3 yrs left)· nominal 20-yr term from priority
A61P 37/04A61P 43/00A61P 35/00A61K 35/646A61P 29/00A61K 31/381A61K 9/0053A61K 38/1767
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition for treating vitiligo and a method of making the same, said composition comprising: a blue scorpion venom; and an alpha lipoic acid. Preferably, the blue scorpion venom is diluted, polarized, and nanosized. Preferably the alpha lipoic acid is polarized and nanosized. The composition may also comprise various vitamins and minerals.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition, said composition comprising:
 a blue scorpion venom; and   an alpha lipoic acid.   
     
     
         2 . The composition of  claim 1 , wherein said blue scorpion venom is diluted in a distilled water, such that a dilute blue scorpion venom is created;
 wherein said dilute blue scorpion venom is polarized, such that a polarized blue scorpion venom is created; and   wherein said alpha lipoic acid is polarized, such that a polarized alpha lipoic acid is created.   
     
     
         3 . The composition of  claim 2 , wherein said polarized blue scorpion venom is polarized by circulating said dilute blue scorpion venom between at least one set of two paired and aligned magnets; and
 wherein said alpha lipoic acid is polarized by circulating said alpha lipoic acid between said at least one set of two paired and aligned magnets.   
     
     
         4 . The composition of  claim 3 , wherein each set of magnets of said at least one set of two paired and aligned magnets mirror each other, such that said magnets repel each other. 
     
     
         5 . The composition of  claim 4 , wherein said polarized blue scorpion venom and said polarized alpha lipoic acid are nanosized. 
     
     
         6 . The composition of  claim 5 , wherein a particle size reduction machine is used to nanosize said polarized blue scorpion venom and said polarized alpha lipoic acid, such that a polarized and nanosized. blue scorpion venom is created and a polarized and nanosized alpha lipoic acid is created. 
     
     
         7 . The composition of  claim 6 , wherein said at least one set of two paired and aligned magnets are operatively coupled to a power source, such that a frequency of said at least one set of two paired and aligned magnets is set. 
     
     
         8 . The composition of  claim 7 , wherein said polarized and nanosized blue scorpion venom and said polarized and nanosized alpha lipoic acid comprise two active ingredients of said composition, and
 wherein said composition is ingested orally by a patient suffering from vitiligo as part of a treatment regimen, such that said patient's skin has an enhanced re-pigmentation.   
     
     
         9 . The composition of  claim 8 , wherein said composition further comprises:
 one or more vitamins.   
     
     
         10 . The composition of  claim 9 , wherein said one or more vitamins comprise:
 vitamin B1;   vitamin B3;   vitamin B6;   vitamin B7;   vitamin B12;   vitamin C;   vitamin D3; and   vitamin E.   
     
     
         11 . The composition of  claim 8 , further comprising:
 one or more minerals.   
     
     
         12 . The composition of  claim 11 , wherein said one or more minerals comprise:
 zinc gluconate;   copper gluconate;   potassium sorbate; and   potassium benzoate.   
     
     
         13 . The composition of  claim 8 , wherein said polarized and nanosized blue scorpion venom is in an amount from 0.00005 to 0.00015 mL in an approximately 15 mL dose of said composition. 
     
     
         14 . The composition of  claim 13 , wherein said polarized and nanosized blue scorpion venom is in an amount of 0.0001 mL in an approximately 15 mL dose of said composition. 
     
     
         15 . The composition of  claim 8 , wherein said polarized and nanosized alpha lipoic acid is in an amount from 0.04 to 0.06 g in an approximately 15 mL dose of said composition. 
     
     
         16 . The composition of  claim 15 , wherein said polarized and nanosized alpha lipoic acid is in an amount of 0.06 g an approximately 15 mL dose of said composition. 
     
     
         17 . A method of treating a condition comprising the steps:
 creating a condition treatment composition comprising: a blue scorpion venom and an alpha lipoic acid;   wherein said condition treatment composition is ingested orally by a patient suffering from vitiligo as part of a treatment regimen, such that said patient's skin has an enhanced re-pigmentation.   
     
     
         18 . The method of  claim 17 , further comprising the steps:
 diluting said blue scorpion venom to create a dilute blue scorpion venom;   polarizing said dilute blue scorpion venom to create a polarized blue scorpion venom;   polarizing said alpha lipoic acid to create a polarized alpha lipoic acid.   
     
     
         19 . The method of  claim 18 , further comprising the steps:
 nanosizing said polarized blue scorpion venom to create a polarized and nanosized blue scorpion venom;   nanosizing said polarized alpha lipoic acid to create a polarized and nanosized alpha lipoic acid;   
     
     
         20 . The method of  claim 19 , wherein said polarized blue scorpion venom and said polarized alpha lipoic acid are polarized by a polarization method comprising the steps:
 providing one or more tubes that are configured to allow said polarized blue scorpion venom or said polarized alpha lipoic acid to circulate through;   providing one or more pairs of magnets, wherein each pair of said one or more pairs of magnets are aligned and spaced apart, such that one of said one or more tubes is sandwiched between said one or more aligned pairs of magnets;   circulating said diluted blue scorpion venom through said one or more tubes; and   circulating said alpha lipoic acid through said one or more tubes;   
       wherein said nanosizing comprises the steps:
 providing a particle size reduction machine; 
 adding said polarized blue scorpion venom to said particle size reduction machine, such that a polarized and nanosized blue scorpion venom is created; and 
 adding said polarized alpha lipoic acid to said particle size reduction machine such that a polarized and nanosized alpha lipoic acid is created.

Join the waitlist — get patent alerts

Track US2017100441A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.